Voluntary License Agreements for Generic Manufacturers: are they an effective path towards improving access to medicines in developing countries?

Code du documentSCP/29/U SHARING SESSION ON LICENSING/ERNESTO CAVELIER
Réunion(s) connexe(s)SCP/29
Date de publication11 décembre 2018
EnglishVoluntary License Agreements for Generic Manufacturers: are they an effective path towards improving access to medicines in developing countries?
Document complet
Voluntary License Agreements for Generic Manufacturers: are they an effective path towards improving access to medicines in developing countries?, single (pdf)
828 KB